The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 8.50
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 1.00 (11.765%)
Open: 9.00
High: 9.00
Low: 9.00
Prev. Close: 9.00
AURA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

22 Jan 2024 08:33

RNS Number : 4478A
Aura Energy Limited
22 January 2024

22 January 2024

Aura Energy Limited

("Aura" or the "Company")

Issue of Equity

Aura Energy Limited (ASX:AEE, AIM:AURA) ("Aura", the "Company") advises that an Appendix 2A (Application for quotation of securities) has been filed with the Australian Securities Exchange ("ASX") and is available on the Company's website: https://auraenergy.com.au/investor-centre/asx-announcements/

The Company has issued ordinary shares at an exercise price of A$0.052 each arising from an exercise of options ("New Shares").

Application will be made for the 552,092 New Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 29 January 2024.

Total Voting Rights

Following the issue of the 552,092 New Shares, the total issued share capital of the Company will consist of 622,209,265 ordinary shares of no par value each ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore, the total current voting rights in the Company following Admission will be 622,209,265 and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

For Further Information, please contact:

David Woodall

Managing Director and CEO

Aura Energy Limited

info@auraenergy.com.au

Paul Ryan

Citadel-MAGNUS

Investor & Media Relations

Pryan@citadelmagnus.com

+61 409 296 511

SP Angel Corporate Finance LLP

(Nominated Advisor and Broker)

David Hignell

Kasia Brzozowska

+44 (0) 203 470 0470

About Aura Energy (ASX:AEE, AIM:AURA)

Aura Energy is an Australian-based minerals company that has major uranium and polymetallic projects with large resources in Africa and Europe. The Company is now focused on uranium production from the Tiris Project, a major greenfield uranium discovery in Mauritania.

A recent Enhanced Feasibility Study has increased the project NPV significantly which reconfirms Tiris as one of the lowest capex, lowest operating cost uranium projects that remain undeveloped in the world.

In October 2021, the Company entered a US$10m Offtake Financing Agreement with Curzon, which includes an additional up to US$10m facility, bringing the maximum available under the agreement to US$20m.

In 2023, Aura will continue to transition from a uranium explorer to a uranium producer, to capitalise on the rapidly growing demand for nuclear power as the world continues to shift towards a decarbonised energy sector.

@AuraEnergyAEE

https://www.linkedin.com/company/aura-energy-limited

Subscribe for Investor Updates

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOEFIFVTLFIFFIS
Date   Source Headline
26th Apr 20248:10 amRNSQuarterly Report for the period ending 31 March 24
23rd Apr 20247:00 amRNSPublication of Prospectus
17th Apr 20249:12 amRNSIssue of Equity
16th Apr 20247:00 amRNSOfftake Agreement with Curzon Uranium Limited
15th Apr 20249:02 amRNSPlacement and Share Purchase Plan Timing - Update
11th Apr 202411:16 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTiris Drilling Results
9th Apr 202412:57 pmRNSHolding(s) in Company
9th Apr 20248:37 amRNSIssue of Equity
8th Apr 20249:07 amRNSIssue of Equity
28th Mar 20247:06 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSAppointment of Chief Financial Officer
25th Mar 20249:33 amRNSCompletion of Tranche 1 Placement Shares - Replace
25th Mar 20247:00 amRNSCompletion of Tranche 1 Placement Shares
20th Mar 202410:16 amRNSIssue of Equity
18th Mar 202410:44 amRNSAppendix 3B
18th Mar 20247:22 amRNSA$16 million placement to advance Tiris Project
18th Mar 20247:00 amRNSRelease of Unlisted Options from Escrow
18th Mar 20247:00 amRNSHalf-year Report
15th Mar 20247:00 amRNSASX Trading Halt
12th Mar 20247:29 amRNSExtensive new uranium mineralisation
6th Mar 20247:35 amRNSIssue of Equity
5th Mar 202411:53 amRNSCancellation of Securities
1st Mar 202412:13 pmRNSRe-weighting of ASX Indices
29th Feb 20247:00 amRNSTiris Project FEED Study Webinar
29th Feb 20247:00 amRNSTotal Voting Rights
28th Feb 20247:02 amRNSFEED study confirms excellent economics for Tiris
26th Feb 20247:11 amRNSSwedish Government inquiry to overturn uranium ban
19th Feb 20247:21 amRNSIssue of Equity
5th Feb 20247:00 amRNSAppendix 3X & Appendix 3Z
5th Feb 20247:00 amRNSIssue of Equity
1st Feb 20247:24 amRNSTotal Voting Rights
30th Jan 20248:58 amRNSQuarterly Report for the Period Ending 31 Dec 23
30th Jan 20247:00 amRNSAura appoints New Managing Director
25th Jan 20247:00 amRNSOption funding agreements secure A$4.3m for Tiris
22nd Jan 20248:33 amRNSIssue of Equity
12th Jan 20247:21 amRNSIssue of Equity
9th Jan 20247:48 amRNSCancellation of securities
5th Jan 20247:00 amRNSExtensional drilling program at Tiris
4th Jan 202412:07 pmRNSIssue of Equity
4th Jan 202411:56 amRNSTotal Voting Rights
22nd Dec 202310:00 amRNSIssue of Equity
20th Dec 202311:43 amRNSIssue of Equity
12th Dec 20237:26 amRNSIssue of Equity
1st Dec 20238:48 amRNSResults of Annual General Meeting - Addendum
30th Nov 20237:00 amRNSTotal Voting Rights
29th Nov 20238:50 amRNSResult of AGM
29th Nov 20237:00 amRNSNew Tiris Project Tenements Applications
21st Nov 20237:27 amRNSIssue of Equity
16th Nov 20238:20 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.